Antibiotic Resistance and Antimicrobial Use in Elderly Patients
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 18309
Special Issue Editors
Interests: medical and surgical emergencies in older adults; acute diverticulitis; acute pancreatitis; sepsis, infection in emergency; procalcitonin; trauma; head trauma; early warning scores; COVID-19; COVID-19 in the elderly
Special Issues, Collections and Topics in MDPI journals
Interests: general medicine; diabetology; geriatric medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The aging population is a worldwide phenomenon. According to the World Health Organization, in almost all countries in the world, the proportion of people over 60 years is increasing faster than other age groups. In 2050, it is expected that people over 60 will amount to almost 2 billion and will represent more than 20% of the population worldwide. In the European Union, it has been estimated that the population over 65 years, in the next 40 years, will double from about 87 million people today to around 148 million. At the same time, the population of the oldest (aged ≥85) is estimated to reach 7.8% of the total population, from the current value of 2.3%.
Elderly patients often present multiple comorbidities and complex clinical conditions compared to younger patients. Elderly patients with multi-morbidity are consequently very heterogeneous in terms of functional status, prognosis, and risk of adverse events.
Bacterial infectious disease and sepsis are common in the elderly population. Sepsis alone accounts for about ¼ of all in-hospital deaths in elderly people. Moreover, in older adults, more than 40% of patients have a recurrent hospitalization within three months of the initial sepsis, most commonly due to a repeat episode of sepsis or another infection.
Antimicrobial use in the elderly population requires a cautious evaluation of underlying clinical conditions, as well as specific adjustments for multi-therapy, reduced kidney and liver function, and potentially harming specific side effects.
At the same time, the optimization of antimicrobial use should take into account the increasing occurrence of Antimicrobial Multi Resistance, which is well recognized as one of the leading threats to human health in the next future.
Antimicrobial use is complex and dynamic and is influenced by sociocultural contexts as well as changing population and individual characteristics, such as the increasing prevalence of multi-morbidity and frailty.
Interventions developed in general clinical practice may not necessarily work for the elderly patients and the interventions to optimize antimicrobial use need to extend beyond a narrow concept of antimicrobial stewardship, and should be based on a comprehensive and inclusive systems approach, informed by a broad research base on the older populations.
This Special Issue invites articles on antimicrobial use in elderly and very elderly patients including (but not limited to) the following topics:
- Specific approaches to antimicrobial therapy in elderly populations;
- Antimicrobial use in the multi-therapy and multi-morbid patients;
- Recurrent infections, sepsis, and antimicrobial therapy in frail patients;
- Antibiotic stewardship in elderly people;
- Changes in microbiota and antibiotic therapy in the elderly;
- Role of new technologies (bacteriophages/probiotics, machine learning, etc.) to control antimicrobial-resistant organisms in the elderly.
Dr. Marcello Covino
Dr. Giuseppe De Matteis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- elderly
- oldest old
- antimicrobial resistance
- antibiotic stewardship
- probiotics
- microbiota
- multi-morbidity
- multi-therapy
- sepsis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.